InvestorsHub Logo
Followers 18
Posts 1147
Boards Moderated 0
Alias Born 09/13/2011

Re: None

Wednesday, 03/28/2018 1:23:47 PM

Wednesday, March 28, 2018 1:23:47 PM

Post# of 8540
A WEEK AWAY!$$$$$$$ Key findings from the trial show that Novavax' trivalent NanoFlu vaccine induced significantly higher hemagglutination inhibition (HAI) antibody responses against homologous A-type strains as well as against historic and forward-drifted H3N2 strains. Based on the strength of these trial results, the Company submitted a related manuscript to a peer-reviewed medical journal and is planning to present the data at the World Vaccine Congress meeting on April 4, 2018.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News